Profil
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Aktive Positionen von Michel Dreano
| Unternehmen | Position | Beginn |
|---|---|---|
Remedys Foundation | Gründer | - |
Ehemalige bekannte Positionen von Michel Dreano
| Unternehmen | Position | Ende |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Finanzdirektor/CFO | 26.04.2019 |
Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Gründer | - |
Ausbildung von Michel Dreano
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
L'Université de Bourgogne
L'Université de Bourgogne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Remedys Foundation |
















